Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
LIPOXEN TECHNOLOGIES LIMITED	LONDON BIOSCIENCE INNOVATION CENTER 2 ROYAL COLLEGE STREET LONDON NW1 0NH

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• B82Y:SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; ....
• A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....
• C07K:PEPTIDES

• 2012 Application Filing Year
• A61K Class
• 11964 Applications Filed
• 9694 Patents Issued To-Date
• 81.03 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Bacon, Andrew	London, GB	5	39
# of filed Patents : 5 Total Citations : 39
Belogurov, Alexey	Moscow, RU	2	4
# of filed Patents : 2 Total Citations : 4
Gabivov, Alexander	Moscow, RU	1	4
# of filed Patents : 1 Total Citations : 4
Gregoriadis, Gregory	London, GB	52	366
# of filed Patents : 52 Total Citations : 366
Ponomarenko, Natalia	Moscow, RU	2	4
# of filed Patents : 2 Total Citations : 4
Smirnov, Ivan	St. Petersburg, RU	3	8
# of filed Patents : 3 Total Citations : 8

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 4 Citation Count
• A61K Class

• 14.18 % this patent is cited more than
• 12 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2014/0086,898

FRAGMENTED POLYMERIC COMPOSITIONS AND METHODS FOR THEIR USE

---

Abstract

---

Cross-linked hydrogels comprise a variety of biologic and non-biologic polymers, such as proteins, polysaccharides, and synthetic polymers. Such hydrogels preferably have no free aqueous phase and may be applied to target sites in a patient's body by extruding the hydrogel through an orifice at the target site. Alternatively, the hydrogels may be mechanically disrupted and used in implantable articles, such as breast implants. When used in vivo, the compositions are useful for controlled release drug delivery, for inhibiting post-surgical spinal and other tissue adhesions, for filling tissue divots, tissue tracts, body cavities, surgical defects, and the like.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.